At a glance
- Originator Abbott Laboratories
- Class
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 14 Feb 2006 No development reported - Preclinical for Cardiovascular disorders in USA (unspecified route)
- 19 Feb 2002 New profile
- 19 Feb 2002 Preclinical development for Cardiovascular disorders in USA (Unknown route)